KQ · Healthcare

Hwail Pharmaceutical Co.Ltd (061250)

Drug Manufacturers - Specialty & Generic

Hwail Pharmaceutical Co.Ltd (061250) is listed on KQ in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 061250

P/E ratio

18.00

Hwail Pharmaceutical Co.Ltd (061250) — FAQ

What is 061250's P/E ratio?

The price-to-earnings (P/E) ratio for Hwail Pharmaceutical Co.Ltd (061250) is 18.00 (data as of 2026-05-24).

Does Hwail Pharmaceutical Co.Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Hwail Pharmaceutical Co.Ltd (061250). Check the MyAverix Finance app for the latest dividend data.

What sector is Hwail Pharmaceutical Co.Ltd in?

Hwail Pharmaceutical Co.Ltd (061250) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 061250 listed on?

061250 is listed on KQ.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)